Clinical Trial Update: Carboplatin-Paclitaxel ± Bevacizumab in Advanced (Stage III-IV) or Recurrent Endometrial Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating carboplatin and paclitaxel with or without bevacizumab in advanced or recurrent endometrial cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Catholic University of the Sacred Heart | Conditions: Stage III-IV or Recurrent Endometrial Cancer | Phase 2 | Status: UNKNOWN